CHELSEA MERROW: Open Payments
NPI 1386260768 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,355 in 128 payments from 16 companies in 2025. Trend: 2023 $1,954 · 2024 $2,153 · 2025 $2,355
Food & beverage: $2,355
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 40 | $528 |
| ABBVIE INC. | 22 | $422 |
| UCB, Inc. | 14 | $267 |
| E.R. Squibb & Sons, L.L.C. | 12 | $229 |
| PFIZER INC. | 8 | $171 |
| AstraZeneca Pharmaceuticals LP | 7 | $167 |
| Janssen Biotech, Inc. | 7 | $154 |
| GENZYME CORPORATION | 3 | $93 |
| Organon LLC | 4 | $81 |
| GlaxoSmithKline, LLC. | 3 | $65 |
Products named: RINVOQ, ORENCIA, EVENITY, Bimzelx, XELJANZ, SAPHNELO, SKYRIZI, TREMFYA.
Industry payments across FL — which companies pay providers there.
